Immediate Impact
59 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
Works of Anna Byrd being referenced
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML
2010
Oral Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anna Byrd | 344 | 126 | 96 | 183 | 10 | 416 | |
| Rafal Falinski | 383 | 215 | 122 | 204 | 8 | 500 | |
| Jan Davisson | 329 | 118 | 92 | 223 | 8 | 443 | |
| Kam-Fai Tse | 312 | 155 | 68 | 159 | 9 | 430 | |
| Paul Cahalin | 414 | 102 | 138 | 190 | 13 | 439 | |
| B P Alter | 221 | 135 | 33 | 233 | 10 | 398 | |
| Kan Luk Cheung | 280 | 84 | 127 | 233 | 11 | 397 | |
| Toshiya Okubo | 302 | 85 | 69 | 252 | 10 | 410 | |
| M Edelstein | 433 | 85 | 130 | 129 | 8 | 464 | |
| Mirjam Klaus | 338 | 125 | 110 | 162 | 10 | 404 | |
| Dushyant Verma | 404 | 282 | 72 | 97 | 14 | 469 |
All Works
Loading papers...